What is the Sell-side Recommending for SJW Group (NYSE:SJW)

What is the Sell-side Recommending for SJW Group (NYSE:SJW)

Wall street brokerage firm analysts are offering a consensus “Buy” rating on shares of SJW Group (NYSE:SJW).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.00 on the shares.  Based on a recent trade, the shares are hovering around $65.34 which, according to analysts, yield significant upside potential to the $68.00 consensus target price. Wall […]

Read More ˃
Stock Price Target in Spotlight: Schweitzer-Mauduit International, Inc. (NYSE:SWM)

Stock Price Target in Spotlight: Schweitzer-Mauduit International, Inc. (NYSE:SWM)

Wall Street brokerage firm analysts have placed a “Buy” rating on shares of Schweitzer-Mauduit International, Inc. (NYSE:SWM).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.00 on the shares.  Based on a recent trade, the shares are hovering around $42.83 which, according to analysts, yield significant upside potential to the $53.50 consensus target price. Wall […]

Read More ˃
Stock Price Target in Spotlight: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

Stock Price Target in Spotlight: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

Analysts on the sell-side are offering a consensus “Buy” rating on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.30 on the shares.  Based on a recent trade, the shares are hovering around $19.34 which, according to the Street, yields significant upside potential to the $28.67 consensus price target Wall […]

Read More ˃
Where Do Analysts See This Stock Going: CTI BioPharma Corp. (NASDAQ:CTIC)

Where Do Analysts See This Stock Going: CTI BioPharma Corp. (NASDAQ:CTIC)

Sell-side analysts are offering a consensus “Buy” rating on shares of CTI BioPharma Corp. (NASDAQ:CTIC).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.00 on the shares.  Based on a recent trade, the shares are hovering around $2.73 which, according to analysts, yield significant upside potential to the $7.50 consensus target price. Wall Street firms […]

Read More ˃
Analysts Slap “Buy” Recommendation on This Stock: North American Energy Partners Inc. (NYSE:NOA)

Analysts Slap “Buy” Recommendation on This Stock: North American Energy Partners Inc. (NYSE:NOA)

Wall Street brokerage firm analysts have placed a “Buy” rating on shares of North American Energy Partners Inc. (NYSE:NOA).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.50 on the shares.  Based on a recent trade, the shares are hovering around $4.40 which, according to analysts, yield significant upside potential to the $6.27 consensus target […]

Read More ˃